Previous Page  168 / 1308 Next Page
Information
Show Menu
Previous Page 168 / 1308 Next Page
Page Background

CT

T2

DCE (ktrans)

ADC

Potential biomarker for prostate cancer progression

• dose escalation

• no compromises in treatment plan

Functional imaging with MR